Meta-analysis of Randomized Controlled Clinical Study on Modified Linggui Zhugan Decoction(苓桂术甘汤) Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure
|更新时间:2021-11-10
|
Meta-analysis of Randomized Controlled Clinical Study on Modified Linggui Zhugan Decoction(苓桂术甘汤) Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure
Journal of Traditional Chinese MedicineVol. 60, Issue 6, Pages: 492-496(2019)
ZHANG Hongyuan, LIU Yue, WANG Yang, et al. Meta-analysis of Randomized Controlled Clinical Study on Modified Linggui Zhugan Decoction(苓桂术甘汤) Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure[J]. Journal of Traditional Chinese Medicine2019, 60(6): 492-496.
ZHANG Hongyuan, LIU Yue, WANG Yang, et al. Meta-analysis of Randomized Controlled Clinical Study on Modified Linggui Zhugan Decoction(苓桂术甘汤) Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure[J]. Journal of Traditional Chinese Medicine2019, 60(6): 492-496.DOI: 10.13288/j.11-2166/r.2019.06.010.
Meta-analysis of Randomized Controlled Clinical Study on Modified Linggui Zhugan Decoction(苓桂术甘汤) Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure
Objective To systematically evaluate the clinical effects of Modified Linggui Zhugan Decoction(苓桂术甘汤) in the treatment of chronic heart failure(CHF). Methods The Chinese National Knowledge Infrastructure(CNKI)
VIP Database
WANFANG Database
China Biology Medicine(CBM)
PubMed and Cochrane library were searched for randomized controlled trials of Modified Linggui Zhugan Decoction in the treatment of CHF by computers
with retrieval time from database establishment to March 31
2018. The control group was treated with routine western medicine
while the treatment group was additionally treated with modified Linggui Zhugan Decoction. The quality evaluation and data extraction were conducted to included literature. The RevMan 5. 3 software was used for data analysis. Results A total of 8 studies were included with 834 cases. Meta-analysis showed that the clinical effective rate of the treatment group was better than the control [RR = 1. 18
95% CI(1. 11
1. 25)
P < 0. 00001].The treatment group improved left ventricular ejection fraction(LVEF)
which was better than the control group[MD = 8. 38
95% CI(2. 65
14. 11)
P = 0. 004]. The treatment group reduced the left ventricular end-diastolic dimension(LVEDD)
which was better than that of the control group [MD =-6. 82
95% CI(-12. 52
-1. 11)
P = 0. 02]. The treatment group reduced the serum NT-proBNP level
which was better than that of the control group[SMD =-3. 53
95% CI(-5. 31
-1. 74)
P < 0. 0001]. The effect of the treatment group on increasing CHF patients’ 6 minutes walking distance was better than that of the control group [MD = 56. 87
95% CI(25. 18
88. 55)
P = 0. 0004]. The grade of evidence showed that the total effective rate
the serum NT-proBNP level and the 6 minute walk distance were extremely low
and LVEF and LVEDD were low. The recommended intensity was weak recommendation. Conclusion Modified Linggui Zhugan Decoction combined with conventional western medicine in the treatment of chronic heart failure can significantly improve the clinical effective rate and LVEF
Effect of Xingeng No.Ⅱ Granules (心梗2号颗粒剂) on Left Ventricular Remodeling in Patients of ST-Segment Elevation Myocardial Infarction with Qi Deficiency and Blood Stasis Syndrome after PCI:An Open-Labbled Randomized-Controlled Trial
Qingre Chushi Decoction (清热除湿汤) in Treating Herpes Zoster with Constraint Heat in the Liver Channel Syndrome:A Multicenter, Randomized Controlled Trial
Effect of Shenqi Jianxin Formula(参芪健心方)on Mitochondrial Autophagy and the PINK1/Parkin Signaling Pathway in Cardiac Tissues in Chronic Heart Failure
Effect of Optimized New Shengmai Powder (优化新生脉散方) on Exercise Tolerance in Patients with Chronic Heart Failure of Qi Deficiency,Blood Stasis and Fluid Retention Syndrome:A Randomized,Double-Blind,Placebo-Controlled Trial
Overview of Study on Syndromic Characteristics and Microscopic Indicators of Qi Deficiency and Blood Stasis Syndrome in Chronic Heart Failure
Related Author
YANG Chunkun
ZHU Qinwei
PAN Qingquan
LI Jun
LIU Zhiyong
QIN Wanli
MA Tengfei
ZHAO Huizhong
Related Institution
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Weifan Hospital of Traditional Chinese Medicine,Shangdong Province
Guang'anmen Hospital,China Academy of Chinese Medical Sciences
Beijing Hospital of Traditional Chinese Medicine,Capital Medical University